Currently, there are 4.71M common shares owned by the public and among those 3.74M shares have been available to trade.
Insiders at the company have transacted a total of 18 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 14 of these insider trades were purchases, accounting for 45,288 shares. Insider sales of the common stock occurred on 4 occasions, with total insider shares sold totaling 14,206 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
However, the script later moved the day high at 3.6699, up 23.21%. The company’s stock has a 5-day price change of 121.15% and 91.57% over the past three months. BRTX shares are trading 98.29% year to date (YTD), with the 12-month market performance up to 10.22% higher. It has a 12-month low price of $1.40 and touched a high of $7.13 over the same period. BRTX has an average intraday trading volume of 39.58K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 100.16%, 93.07%, and 19.83% respectively.
Institutional ownership of BioRestorative Therapies Inc (NASDAQ: BRTX) shares accounts for 17.56% of the company’s 4.71M shares outstanding.
It has a market capitalization of $16.25M and a beta (3y monthly) value of 62.34. The earnings-per-share (ttm) stands at -$4.12. Price movements for the stock have been influenced by the stock’s volatility, which stands at 21.88% over the week and 11.28% over the month.
Analysts forecast that BioRestorative Therapies Inc (BRTX) will achieve an EPS of -$0.67 for the current quarter, $0 for the next quarter and -$2.53 for 2024. The lowest estimate earnings-per-share for the quarter is -$0.67 while analysts give the company a high EPS estimate of -$0.67. Comparatively, EPS for the current quarter was -$1.19 a year ago. Earnings per share for the fiscal year are expected to increase by 30.14%, and 36.97% over the next financial year.
